Press release
Non-Alcoholic Steatohepatitis (NASH) - Pipeline Drugs and Companies Insight Report, 2023 Updates: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments
Non-Alcoholic Steatohepatitis (NASH)
Download PDF Sample Pages to Get an in-depth Assessment of the Emerging Therapies and Key Companies: https://www.globalinsightservices.com/request-sample/GIS31203
Key Players
180 Life Corp
89bio, Inc.
Acquist Theraputics Inc
Akero Therapeutics, Inc
Algernon Pharmaceuticals Inc
Aligos Therapeutics
Allysta Pharmaceuticals Inc
Report Highlights
Global Insight Service's, Nonalcoholic Steatohepatitis (NASH) - Drug Pipeline Landscape, 2023 report provides an overview of the Non-alcoholic steatohepatitis pipeline drugs. This report covers detailed insights on Nonalcoholic Steatohepatitis (NASH) drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Nonalcoholic Steatohepatitis (NASH) pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.
Methodology
The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.
Scope
The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clinical trials, and key upcoming milestones are included.
Buy Now: https://www.globalinsightservices.com/checkout/single_user/GIS31203
Report Covers the Emerging Pipeline Products Under Different Phases of Clinical Development Like
- Late-stage products (Phase III)
- Mid-stage products (Phase II)
- Early-stage product (Phase I)
- Pre-clinical and Discovery stage candidates
- Discontinued & Inactive candidates
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust and transparent research methodology, and superior service.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Non-Alcoholic Steatohepatitis (NASH) - Pipeline Drugs and Companies Insight Report, 2023 Updates: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments here
News-ID: 2949163 • Views: …
More Releases from Global Insight Services
Submersible Pump Market Is Anticipated To Expand From $14.5 Billion In 2024 To $ …
Market Overview
The Submersible Pump Market is anticipated to expand from $14.5 billion in 2024 to $21.8 billion by 2034, registering a steady CAGR of approximately 4.2%. Submersible pumps are designed for submerged operations in various fluids, enabling efficient water extraction, sewage treatment, and oil and gas applications. These pumps are extensively used across sectors such as agriculture, municipal infrastructure, and industrial processes, offering reliable performance in demanding environments. The market's…
Special Mission Aircraft Market Is Anticipated To Expand From $17.3 Billion In 2 …
Market Overview
The Special Mission Aircraft Market is witnessing substantial expansion, driven by the rising need for versatile and technologically advanced aircraft tailored for unique operational roles. These aircraft are not limited to traditional transport duties but are equipped for specific missions such as intelligence gathering, surveillance, reconnaissance, search and rescue, and maritime patrol. As defense and homeland security agencies worldwide focus on enhancing situational awareness and operational efficiency, the Special…
Medical Tourism Market Is Anticipated To Expand From $115.6 Billion In 2024 To $ …
Market Overview
The Medical Tourism Market has emerged as a transformative force within the global healthcare ecosystem, offering patients an affordable and accessible alternative to high-cost treatments in their home countries. It represents a growing trend where individuals travel abroad to receive medical services ranging from elective cosmetic procedures to complex surgeries. The demand surge is primarily fueled by cost-effectiveness, high-quality care, shorter waiting times, and the availability of advanced treatments…
Magnetic Sensor Market Is Anticipated To Expand From $5.42 Billion In 2024 To $1 …
Market Overview
The Magnetic Sensor Market is anticipated to expand from $5.42 billion in 2024 to $12.48 billion by 2034, growing at a CAGR of approximately 8.7%. This rapid growth reflects the rising integration of magnetic sensing technologies across diverse industries such as automotive, consumer electronics, healthcare, and industrial automation. These sensors are essential for detecting magnetic fields and translating them into electrical signals, enabling applications like navigation, position sensing, current…
More Releases for Steatohepatitis
Nonalcoholic Steatohepatitis (NASH) Market Massive Growth opportunity Ahead
Introduction
Nonalcoholic Steatohepatitis (NASH) is an advanced form of nonalcoholic fatty liver disease (NAFLD) characterized by fat accumulation in the liver along with inflammation and liver cell damage. If left untreated, NASH can progress to fibrosis, cirrhosis, liver failure, or hepatocellular carcinoma. Closely tied to the global obesity and diabetes epidemic, NASH has become a major healthcare burden, with millions affected worldwide and no widely approved curative therapy to date.
The NASH…
Non-Alcoholic Steatohepatitis Treatment Market Size, Share
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Non-Alcoholic Steatohepatitis Treatment Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $2.67 billion In 2028…
Non-Alcoholic Steatohepatitis (NASH) - Drug Pipeline Landscape, 2023
Nonalcoholic steatohepatitis (NASH) is a type of fatty liver disease. It is characterized by the accumulation of fat in the liver, inflammation, and damage. NASH can lead to cirrhosis, liver failure, and death. The exact cause of NASH is unknown, but it is believed to be associated with obesity, insulin resistance, and diabetes. Treatment of NASH is focused on weight loss, exercise, and the control of diabetes and insulin resistance.
NASH…
Non Alcoholic Steatohepatitis (NASH) Market Size to Hit $21,879 Million by 2028 …
According to our experience research team, Non Alcoholic Steatohepatitis (NASH) Market was valued at USD 1,569 Million in 2021, and the global Non Alcoholic Steatohepatitis (NASH) industry is projected to reach a value of USD 21,879 Million by 2028, at a CAGR of 60.4% during the forecast period 2022-2028
The report is focused on gaining various Non Alcoholic Steatohepatitis (NASH) market trends, dynamics, growth drivers, opportunities, weaknesses, strengths, and threats restraining…
Nonalcoholic Steatohepatitis Treatment Market Analysis
As per the research conducted by GME, the Global Nonalcoholic Steatohepatitis Treatment Market will grow with a CAGR value of 39.1% by 2026. Over the forecast era, the production of NASH biomarkers is expected to be aided by increasing demand for non-invasive diagnostic tools and increased patient awareness. The low use of invasive procedures for disease diagnosis is due to the high cost of liver biopsy, its invasiveness, and patients'…
Emerging Opportunities in Nonalcoholic Steatohepatitis Therapeutics Market
Global Nonalcoholic Steatohepatitis (NASH) Market: Snapshot
Nonalcoholic Steatohepatitis (NASH), a syndrome found in non-alcoholic patients, causes damage to liver that is histologically akin to alcoholic hepatitis. NASH results from fat in the liver, along with inflammation. Symptoms in NASH usually do not show, but it can be severe and lead to cirrhosis, which is permanent damage to the liver.
Those suffering from obesity, dyslipidemia, and glucose intolerance are most likely…
